Auteurs
Jessica Zucman-Rossi,
Primary liver cancer (PLC) is the third leading cause of cancer death, accounting for 830,180 deaths worldwide in 2020. PLCs are mainly composed of hepatocellular carcinoma (HCC, ∼85%) and intrahepatic cholangiocarcinoma (iCCA, ∼10%).
HCC is PLC characterized by hepatocellular differentiation; in contrast, CCAs are biliary differentiated tumors. HCC and iCCA define a spectrum of PLCs that also include mixed tumors (combined HCC-CCA [cHCC-CCA]), which are much more uncommon (∼1%). They are defined by the presence of HCC and CCA areas in various proportions, as well as, in some cases, the presence of transitional features within the same tumor.
Autres publications
01 Fév 2026
Auteurs :
Agathe Hercent,
Julien Masliah-Planchon,
David Cohen,
Rémy Nicolle,
Jean-Yves Scoazec,
Philippe Ruszniewski,
Ivan Bièche,
Louis De Loureiro,
Anne Couvelard,
Jérome Cros,
19 Déc 2025
Auteurs :
Agathe Hercent,
Julien Masliah‐Planchon,
David Cohen,
Rémy Nicolle,
Jean‐Yves Scoazec,
Philippe Ruszniewski,
Ivan Bièche,
Louis De Loureiro,
Anne Couvelard,
Jérome Cros,
Predictive value of metabolic state on PanNET response to mTOR inhibitors
Endocr Relat Cancer
28 Sep 2025
Auteurs :
Jérome Cros,
Margot Bucau,
Matthieu Tihy,
Maxime Palazzo,
Pierre Bourgoin,
Anais Chassac,
Miguel Albuquerque,
Alain Sauvanet,
Safi Dokmak,
Marco DioguardiBurgio,
Valérie Paradis,
Olivia Hentic,
Philippe Ruszniewski,
Louis De Loureiro,
Vinciane Rebours,
Anne Couvelard,
Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations
Scientific Reports
21 Août 2025
Auteurs :
Paulina Dragan,
Valérie Gratio,
Thierry Voisin,
Alain Couvineau,
Dorota Latek,

